{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:06:36Z","timestamp":1747166796932,"version":"3.40.5"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.leukres.2018.04.015","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T05:39:26Z","timestamp":1525066766000},"page":"13-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7567-4331","authenticated-orcid":false,"given":"Sohee","family":"Ryu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Sue","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyongok","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Mee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Soon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","key":"10.1016\/j.leukres.2018.04.015_bib0005"},{"issue":"2","key":"10.1016\/j.leukres.2018.04.015_bib0010","first-page":"148","article-title":"Acute erythroid neoplastic proliferations. A biological study based on 62 patients","volume":"87","author":"Domingo-Claros","year":"2002","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.leukres.2018.04.015_bib0015","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/sj.leu.2403316","article-title":"Erythroleukaemia and RAEB-t: a same disease?","volume":"18","author":"Park","year":"2004","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.leukres.2018.04.015_bib0020","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2009-09-243964","article-title":"Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification","volume":"115","author":"Hasserjian","year":"2010","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.leukres.2018.04.015_bib0025","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"year":"2001","series-title":"Human Cytogenetics: Malignancy and Acquired Abnormalities","author":"Rooney","key":"10.1016\/j.leukres.2018.04.015_bib0030"},{"year":"2005","series-title":"International Standing Committee on Human Cytogenetic Nomenclature, ISCN 2005: an International System for Human Cytogenetic Nomenclature (2005): Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature, Basel","author":"Shaffer","key":"10.1016\/j.leukres.2018.04.015_bib0035"},{"issue":"10","key":"10.1016\/j.leukres.2018.04.015_bib0040","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/modpathol.2016.118","article-title":"Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts","volume":"29","author":"Wang","year":"2016","journal-title":"Modern Pathol."},{"issue":"1","key":"10.1016\/j.leukres.2018.04.015_bib0045","first-page":"2","article-title":"Acute myeloid leukemia and acute promyelocytic leukemia","volume":"8","author":"Lowenberg","year":"2003","journal-title":"Hematology: Am. Soc. Hematol."},{"issue":"2","key":"10.1016\/j.leukres.2018.04.015_bib0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cancergencyto.2005.05.006","article-title":"Cytogenetic study of 75 erythroleukemias","volume":"163","author":"Lessard","year":"2005","journal-title":"Cancer Genet. Cytogenet."},{"issue":"4","key":"10.1016\/j.leukres.2018.04.015_bib0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/gcc.10180","article-title":"De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19, Genes","volume":"36","author":"Cigudosa","year":"2003","journal-title":"Chromosomes Cancer"},{"issue":"11","key":"10.1016\/j.leukres.2018.04.015_bib0060","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1182\/blood.V80.11.2873.2873","article-title":"Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia","volume":"80","author":"Olopade","year":"1992","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2018.04.015_bib0065","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/leu.2009.181","article-title":"Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution","volume":"23","author":"Santos","year":"2009","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2018.04.015_bib0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.leukres.2006.10.023","article-title":"Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes","volume":"31","author":"Olney","year":"2007","journal-title":"Leuk. Res."},{"issue":"12","key":"10.1016\/j.leukres.2018.04.015_bib0075","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0145-2126(03)00104-8","article-title":"Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study","volume":"27","author":"Cherry","year":"2003","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.leukres.2018.04.015_bib0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-4608(01)00533-7","article-title":"Predominance of trisomy 1q in myelodysplastic syndromes in Korea: is there an ethnic difference? A 3-year multi-center study","volume":"132","author":"Lee","year":"2002","journal-title":"Cancer Genet. Cytogenet."},{"issue":"4","key":"10.1016\/j.leukres.2018.04.015_bib0085","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2018.04.015_bib0090","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3324\/haematol.10869","article-title":"A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia","volume":"92","author":"Bacher","year":"2007","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.leukres.2018.04.015_bib0095","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618301012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618301012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T02:47:33Z","timestamp":1571280453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212618301012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":19,"alternative-id":["S0145212618301012"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2018.04.015","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2018.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}